Model for Alternative Splicing of Insulin Receptor in Myotonic Dystrophy Type 1

被引:1
作者
Tonevitsky, E. A. [1 ]
Trushkin, E. V. [1 ]
机构
[1] Russian Res Inst Sport & Phys Educ, Moscow, Russia
关键词
myotonic dystrophy; model of splicing regulation; CTG REPEAT; PROTEINS; MBNL;
D O I
10.1007/s10517-009-0611-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Muscular dystrophy is a common multisystem disease, which results from the impairment of alternative splicing. An increase in the number of unstable CTG and CCTG repeats in untranslated regions of the DMPK and ZNF9 genes is followed by dysregulation of RNA-binding proteins. Further changes are followed by dysfunction of insulin receptors, membrane Cl- channels, and other proteins. We developed a new mathematical model for the regulation of splicing of exon 11 in the IR gene, which describes the effect of various factors on alternative splicing.
引用
收藏
页码:772 / 776
页数:5
相关论文
共 50 条
[21]   Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy [J].
Fugier, Charlotte ;
Klein, Arnaud F. ;
Hammer, Caroline ;
Vassilopoulos, Stephane ;
Ivarsson, Ylva ;
Toussaint, Anne ;
Tosch, Valerie ;
Vignaud, Alban ;
Ferry, Arnaud ;
Messaddeq, Nadia ;
Kokunai, Yosuke ;
Tsuburaya, Rie ;
de la Grange, Pierre ;
Dembele, Doulaye ;
Francois, Virginie ;
Precigout, Guillaume ;
Boulade-Ladame, Charlotte ;
Hummel, Marie-Christine ;
Lopez de Munain, Adolfo ;
Sergeant, Nicolas ;
Laquerriere, Annie ;
Thibault, Christelle ;
Deryckere, Francois ;
Auboeuf, Didier ;
Garcia, Luis ;
Zimmermann, Pascale ;
Udd, Bjarne ;
Schoser, Benedikt ;
Takahashi, Masanori P. ;
Nishino, Ichizo ;
Bassez, Guillaume ;
Laporte, Jocelyn ;
Furling, Denis ;
Charlet-Berguerand, Nicolas .
NATURE MEDICINE, 2011, 17 (06) :720-U112
[22]   Changes in RNA splicing as a surrogate endpoint for myotonic dystrophy Type 1 (DM1) clinical trials [J].
Berglund, J. Andrew ;
Novack, Aaron ;
Ivanovska Holder, Iva ;
Ray, Soma ;
Johnson, Nicholas E. .
JOURNAL OF NEUROMUSCULAR DISEASES, 2025,
[23]   Muscular disability and organ impairments in myotonic dystrophy type 1 [J].
Pruna, L. ;
Machado, F. ;
Louis, L. ;
Vasse, G. ;
Kaminsky, P. .
REVUE NEUROLOGIQUE, 2011, 167 (01) :23-28
[24]   Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1 [J].
Stoodley, Jessica ;
Vallejo-Bedia, Francisco ;
Seone-Miraz, David ;
Debasa-Mouce, Manuel ;
Wood, Matthew J. A. ;
Varela, Miguel A. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
[25]   Respiratory dysfunction in myotonic dystrophy type 1: A systematic review [J].
Hawkins, A. M. ;
Hawkins, C. L. ;
Razak, K. Abdul ;
Khoo, T. K. ;
Tran, K. ;
Jackson, R. V. .
NEUROMUSCULAR DISORDERS, 2019, 29 (03) :198-212
[26]   Myotonic Dystrophy Type 1 Management and Therapeutics [J].
Cheryl A. Smith ;
Laurie Gutmann .
Current Treatment Options in Neurology, 2016, 18
[27]   Pathogenesis of myotonic dystrophy type 1. [J].
Magana, Jonathan J. ;
Leyva-Garcia, Norberto ;
Cisneros, Bulmaro .
GACETA MEDICA DE MEXICO, 2009, 145 (04) :331-337
[28]   Multiorgan manifestations in myotonic dystrophy type 1 [J].
Varga David ;
Pal Endre .
ORVOSI HETILAP, 2019, 160 (37) :1447-1454
[29]   Update on Therapy for Myotonic Dystrophy Type 1 [J].
Ivanovic, Vukan ;
Meola, Giovani ;
Vukojevic, Zoran ;
Peric, Stojan .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2023, 25 (08) :261-279
[30]   Oxidative stress in myotonic dystrophy type 1 [J].
Toscano, A ;
Messina, S ;
Campo, GM ;
Di Leo, R ;
Musumeci, O ;
Rodolico, C ;
Aguennouz, M ;
Annesi, G ;
Messina, C ;
Vita, G .
FREE RADICAL RESEARCH, 2005, 39 (07) :771-776